Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2025-12-25 @ 4:09 AM
NCT ID:
NCT00002420
Eligibility Criteria:
Inclusion Criteria
You may be eligible for this study if you:
* Are HIV-positive.
* Are at least 18 years old.
* Have experienced treatment failure on a previous anti-HIV drug combination that contained at least one protease inhibitor. Your viral load must be between 5,000 and 50,000 copies/ml after 6 months of continuous treatment with that drug combination.
* Agree to use a barrier method of birth control, such as condoms, during the study.
Exclusion Criteria
You will not be eligible for this study if you:
* Have a history of certain medical conditions, such as pancreatitis, peripheral neuropathy, seizure disorder, or AIDS-related cancer (except for Kaposi's sarcoma).
* Are allergic to any of the study drugs.
* Have ever taken certain anti-HIV medications including non-nucleoside reverse transcriptase inhibitors (NNRTIs), ddI, or d4T.
* Have taken certain other medications including interleukin-2, interferon or a vaccine within 30 days of study entry.
* Have received radiation therapy or chemotherapy within 30 days of study entry. (Local radiation therapy is allowed.)
* Abuse alcohol or drugs.
* Are pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00002420
Study Brief:
Protocol Section:
NCT00002420